ACONW Aclarion, Inc. - Fundamental Analysis

BEARISH

ACONW Stock | Fundamental Analysis & Investment Insights

NASDAQ • N/A • N/A

Current Price Live

$0.03

52W High

$0.04

52W Low

$0.03

Overview AI Snowflake Price Valuation Profitability Growth Health

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Feb 14, 2026

Market cap

N/A

P/E

N/A

ROE

-97.7%

Profit margin

N/A

Debt/Equity

N/A

Dividend yield

N/A

AI Analysis

Confidence Score

92%

Analysis Accuracy

ACONW exhibits weak financial health with a Piotroski F-Score of 5/9, indicating a stable but fragile position, and lacks an Altman Z-Score, raising unquantified distress risk. The company shows negative profitability across all key metrics—ROE at -97.72%, operating margin at -9,666.16%, and gross margin at -7.83%—signaling severe operational inefficiencies. Despite a 31.5% YoY revenue growth, the absence of earnings, cash flow, and meaningful valuation metrics (e.g., P/E, Price/Book) undermines growth credibility. The stock trades near its 52-week low at $0.034, with no analyst coverage or dividend, and technical indicators are bearish. Overall, the company is fundamentally unsound despite modest top-line expansion.

Key Strengths

31.5% year-over-year revenue growth indicates potential market traction

High current and quick ratios (17.01 and 16.31) suggest strong short-term liquidity

No reported debt (implied by N/A Debt/Equity and high liquidity)

Low float and market cap may enable volatility for speculative traders

Recent price stability near 52-week low may present a technical floor

Key Risks

Negative operating margin of -9,666.16% indicates severe operational losses

ROE of -97.72% and ROA of -52.37% signal deep capital destruction

No meaningful profitability or cash flow generation despite revenue growth

Missing key valuation metrics (P/E, PEG, Price/Book) limit analytical grounding

No analyst coverage, dividend, or insider buying signals long-term neglect

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall

Weak

Value

Future

Past

Health

Dividend

AI Verdict

High Risk

Key drivers: Negative profitability across all metrics, Lack of valuation and cash flow data, Weak Piotroski F-Score with no Altman Z-Score, No analyst coverage or dividend, Technical trend is bearish

Confidence

90%

Value

15/100

Ref P/E, PEG, Graham Number

Positives

Revenue growth of 31.5% suggests top-line momentum

Watchpoints

No P/E, PEG, or Price/Book ratios available
Graham Number not calculable due to negative earnings
Intrinsic value estimate unavailable
Stock trades at near 52-week low with no valuation support

Future

35/100

Ref Growth rates

Positives

31.5% YoY revenue growth indicates potential expansion

Watchpoints

No earnings growth data available
No free cash flow or operating cash flow metrics
No forward guidance or analyst estimates
Growth not translating into profitability

Past

20/100

Ref Historical trends

Positives

High current and quick ratios suggest strong liquidity history

Watchpoints

Persistent negative margins and ROE/ROA
No historical profitability or cash flow trends
No dividend history or payout record
Price has not moved meaningfully over 5 years

Health

18/100

Ref Altman Z-Score, Piotroski F-Score

Positives

High current and quick ratios indicate strong liquidity

Watchpoints

Piotroski F-Score of 5/9 is below the strong threshold
No Altman Z-Score available, implying unassessed bankruptcy risk
Negative ROE and ROA indicate capital erosion
Operating margin is catastrophically negative

Dividend

0/100

Ref Yield, Payout

Positives

No standout positives identified.

Watchpoints

Dividend yield and rate are N/A
Payout ratio not applicable
No history of dividend payments
Dividend strength score is 0/100

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price

$0.03

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ACONW and closest competitors.

Updated 2026-02-13

Company	5Y	3Y	1Y	6M	1M	1W
ACONW Aclarion, Inc. Primary	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

N/A

0.0

N/A

Profitability

Profit margins and return metrics

Profit Margin N/A

Operating Margin -9666.16%

Gross Margin -7.83%

ROE -97.72%

ROA -52.37%

Growth

Revenue and earnings growth rates

Revenue Growth +31.5%

Earnings Growth N/A

Q/Q Revenue Growth N/A

Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity

N/A

Current Ratio

17.01

Strong

Quick Ratio

16.31

Excellent

Cash/Share

$16.95

Past News Coverage

Recent headlines mentioning ACONW from our newsroom.

Newest → oldest

Back to All Stocks

TradingGPT V1 Copilot

Fundamentals • Valuation • Risk

Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends